Meissa Vaccines
Latest round
- Series A
Last raised
- Sep 2019
Total raised
- $14M
Investors
- 2
About Meissa Vaccines
Meissa Vaccines, Inc. is focused on developing innovative vaccine solutions targeting respiratory viruses, particularly for public health challenges.Founded in 2014, Meissa Vaccines, Inc. operates from Redwood City, US, specializing in vaccine development.Meissa Vaccines specializes in the development of innovative vaccine solutions aimed at addressing global public health challenges. The company’s core offerings are primarily centered around its proprietary vaccine candidates designed to combat respiratory viruses, with a particular focus on respiratory syncytial virus (RSV). The vaccines are engineered to enhance efficacy and safety profiles, providing significant value to healthcare providers and high-risk populations.The revenue model of Meissa Vaccines is structured around strategic partnerships and B2B transactions with healthcare providers and institutions. The company engages directly with clients through contractual agreements for bulk purchases of its vaccine products. Meissa Vaccines' flagship products are competitively priced in alignment with industry standards, fostering accessibility while supporting sustainability for ongoing research and development efforts. The company aims to launch additional vaccine products targeting respiratory viruses within the next few years, and is exploring expansion into European and Asian markets to increase accessibility. These initiatives are designed to enhance its growth trajectory and address the identified public health challenges in these regions.
Who invested in Meissa Vaccines
2 investors across 2 rounds
See all investors in Meissa Vaccines
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Meissa Vaccines
Who invested in Meissa Vaccines?
Meissa Vaccines has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Meissa Vaccines raised?
Meissa Vaccines has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Meissa Vaccines last raise money?
Meissa Vaccines's most recent round on record is a Series A, in Sep 2019.
What does Meissa Vaccines do?
Meissa Vaccines is a biotechnology company.
Where is Meissa Vaccines headquartered?
Meissa Vaccines is headquartered in Redwood City, US.
Which VCs invest in companies like Meissa Vaccines?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Meissa Vaccines's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Meissa Vaccines? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.